MedTrace Logo

Effects of Pomegranate Seed Oil and Mediterranean Diet on MCI

NCT04990362 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-12-14

No results posted yet for this study

Summary

A double-blind clinical trial of pomegranate oil and Mediterranean diet that will be carried out on 60 patients with Mild Cognitive Impairment (MCI) and APOE ε3 and ε4 allele.

The aim of the research is to examine if the Mediterranean diet with pomegranate oil and without it can bring positive changes in patients with MCI in terms of motor and cognitive skills.

Conditions

Interventions

DIETARY_SUPPLEMENT

Pomegranate oil, Mediterranean Diet

Dietary Supplement: Pomegranate oil in a glass bottle of 0.15ml per day +Mediterranean dietary protocol Dietary Supplement: Mediterranean dietary protocol

DIETARY_SUPPLEMENT

Mediterranean Diet

Dietary Supplement: Mediterranean dietary protocol

Sponsors & Collaborators

  • Greek Alzheimer's Association and Related Disorders

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Magda Tsolaki, MD PhD Prof. · Greek Alzheimer's Association and Related Disorders

  • Thanos Chatzikostopoulos, MSc · Greek Alzheimer's Association and Related Disorders

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04990362 on ClinicalTrials.gov